Hexamer Therapeutics
hexamertherapeutics.com
Biotechnology
Vaccines
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$1.6M
3 rounds on record
Latest round
$500k
Venture round · Jul 2026 · 3 mo ago
Team
1-10
employees, estimated range
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 7
Raised a round Venture round $500k · SEC Form D
Jan 1, 2024
Raised a round Venture round $651k · SEC Form D
Nov 15, 2019
Raised a round Venture round $470k · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2026 | $500k | — | SEC Form D |
| Venture round | Jan 2024 | $651k | — | SEC Form D |
| Venture round | Nov 2019 | $470k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Hexamer Therapeutics, Inc | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Robert BogdenExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
404 Err….or The vaccines you're looking for don't exist. Yet….
Animal Vaccine Delivery in Just 30 Minutes. Experience the world's fastest vaccine delivery. Get a complete range of vaccines delivered…
Explore our innovative broad-spectrum, mutation-agnostic vaccines that are revolutionizing immunization. Discover the enduring, economic…
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…
Protecting against viral threats. Ushering in a new era of AI-enabled vaccine design.
Overview
Innovators in natural vaccine technology. Explore rapidly engineered, scalable vaccine technologies at Hexamer Therapeutics.
People
Robert Bogden
Executive Officer, Director
Colin Collins
Director
Keith Miller
Director
R. Scott Blackley
Director
Stephen Crawford
Director
Brad Call
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pullman
United States
HQ
1-10 est. staff